Página 26 - Small Cap U.S. Pharmaceuticals & Biotech Acciones por capitalización bursátil

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

ACTUALIZADO Jun 10, 2026

Descubra las empresas de pequeña capitalización U.S. Pharmaceuticals & Biotech que cotizan en NYSE y NASDAQ. Estas Pharmaceuticals & Biotech Companies están organizadas por capitalización bursátil.

712 empresas

Empresa	Último precio	7D Retorno	Rendimiento 1 año	Capitalización bursátil	Objetivo de los analistas	Valoración	Crecimiento	Div Rendimiento
RCUS	US$22.12	-7.3%	143.6%	US$3.0b	US$35.75	11.8	28.7%	n/a
BEAM	US$29.49	-0.2%	64.8%	US$3.0b	US$51.07	17.9	-1.2%	n/a
RLAY	US$13.49	-11.8%	303.9%	US$3.1b	US$24.25	275.4	14.1%	n/a
DNLI	US$20.61	4.8%	35.7%	US$3.3b	US$33.93	3.5	37.9%	n/a
VKTX	US$27.75	-5.4%	-4.1%	US$3.4b	US$92.58	6.4	29.4%	n/a
OGN	US$13.38	-0.1%	32.7%	US$3.5b	US$11.25	14.3	30.6%	0.6%
NAMS	US$29.33	-8.7%	43.1%	US$3.6b	US$50.16	152.0	65.3%	n/a
EWTX	US$32.92	-9.1%	109.0%	US$3.7b	US$46.08	7.2	25.0%	n/a
CRNX	US$34.32	3.7%	6.2%	US$3.7b	US$83.14	200.3	51.3%	n/a
ACAD	US$21.25	-0.8%	-4.7%	US$3.7b	US$31.65	9.7	12.1%	n/a
KNSA	US$49.27	3.0%	63.0%	US$3.7b	US$63.50	51.9	31.9%	n/a
CPRX	US$31.34	0.2%	23.3%	US$3.8b	US$32.60	17.3	8.7%	n/a
TXG	US$29.11	-9.5%	170.0%	US$3.9b	US$25.77	5.8	5.5%	n/a
VCYT	US$48.17	-1.1%	72.5%	US$3.9b	US$49.10	43.7	6.9%	n/a
MANE	US$92.98	-3.9%	n/a	US$4.0b	US$132.25	9.9	47.1%	n/a
ORKA	US$64.03	11.9%	408.2%	US$4.0b	US$142.17	8.0	-27.6%	n/a
ERAS	US$13.37	1.4%	779.6%	US$4.2b	US$21.00	10.6	10.4%	n/a
TWST	US$67.77	-6.3%	92.8%	US$4.4b	US$64.38	10.3	40.7%	n/a
CELC	US$88.24	-0.8%	606.5%	US$4.5b	US$161.09	80.4	66.3%	n/a
TVTX	US$46.74	3.4%	221.9%	US$4.5b	US$55.07	8.1	50.4%	n/a
TNGX	US$28.68	33.6%	505.1%	US$4.6b	US$40.45	72.8	19.4%	n/a
DNTH	US$76.42	-10.1%	321.7%	US$4.6b	US$127.67	3126.9	26.9%	n/a
INDV	US$38.09	7.5%	178.8%	US$4.7b	US$51.50	18.4	13.8%	0%
AMRX	US$15.32	19.0%	96.9%	US$4.7b	US$17.20	40.0	41.4%	0%

Page 26 of 30